Press Releases April 1, 2026

Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026

Merit Medical Systems announces Q1 2026 earnings release and investor call scheduled for April 30, 2026

By Derek Hwang MMSI
Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026
MMSI

Merit Medical Systems, a global healthcare technology company specializing in proprietary medical devices, will release its financial results for Q1 2026 after market close on April 30, 2026, followed by an investor conference call.

Key Points

  • Merit Medical Systems focuses on medical devices used in interventional, diagnostic, and therapeutic procedures across multiple specialties including cardiology, radiology, oncology, critical care, and endoscopy.
  • The company plans to release financial results and hold a conference call on April 30, 2026.
  • Merit employs approximately 7,600 individuals and serves customers globally through a robust sales and clinical support team.

SOUTH JORDAN, Utah, April 02, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended March 31, 2026, after the close of the stock market on Thursday, April 30, 2026. Merit plans to hold its investor conference call on the same day (Thursday, April 30, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific).

To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details.

A live webcast and slide deck can be accessed using this link. A link to both register for the conference call and view the webcast will be made available at www.merit.com.

ABOUT MERIT

Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,600 people worldwide.

Contacts:
   PR/Media Inquiries:
Sarah Comstock
Merit MedicalInvestor Inquiries:
Mike Piccinino, CFA, IRC
ICR Healthcare+1-801-432-2864+1-443-213-0509sarah.comstock@[email protected]

Risks

  • Financial results may fall short of investor expectations impacting stock performance.
  • Market conditions in healthcare technology and medical device sectors could impact operational results.
  • Uncertainties related to global healthcare regulations and supply chain disruptions might affect company performance.

More from Press Releases

Jena Acquisition Corporation II Announces Non-Compliance with Section 802.01B of the NYSE Listed Company Manual which Requires the Company to Maintain a Minimum of 300 Public Stockholders Apr 3, 2026 Midland States Bancorp, Inc. To Announce First Quarter 2026 Financial Results On Thursday, April 23 Apr 3, 2026 Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Apr 3, 2026 Multi-Sensor Data Labeling and AI Data Operations: What Enterprise AV Teams Apr 3, 2026 Wix Announces Final Results of Modified Dutch Auction Tender Offer Apr 3, 2026